Invesco
BNTX icon

Invesco’s BioNTech BNTX Stock Holding History

Invesco’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.35M Buy
100,462
+8,662
+9% +$815K ﹤0.01% 1936
2026
Q1 		$8.16M Buy
91,800
+10,959
+14% +$1.13M ﹤0.01% 1946
2025
Q4 		$7.7M Buy
80,841
+6,685
+9% +$674K ﹤0.01% 2018
2025
Q3 		$7.31M Sell
74,156
-606,944
-89% -$64.9M ﹤0.01% 2021
2025
Q2 		$72.5M Buy
681,100
+35,958
+6% +$3.63M 0.01% 917
2025
Q1 		$58.7M Buy
645,142
+558,389
+644% +$62.5M 0.01% 976
2024
Q4 		$9.89M Sell
86,753
-1,005
-1% -$115K ﹤0.01% 1869
2024
Q3 		$10.4M Buy
87,758
+6,247
+8% +$574K ﹤0.01% 1817
2024
Q2 		$6.55M Sell
81,511
-19,975
-20% -$1.83M ﹤0.01% 2041
2024
Q1 		$9.36M Buy
101,486
+14,524
+17% +$1.39M ﹤0.01% 1855
2023
Q4 		$9.18M Buy
86,962
+2,627
+3% +$265K ﹤0.01% 1873
2023
Q3 		$9.16M Buy
84,335
+5,800
+7% +$641K ﹤0.01% 1821
2023
Q2 		$8.48M Buy
78,535
+5,375
+7% +$605K ﹤0.01% 1921
2023
Q1 		$9.11M Buy
73,160
+5,431
+8% +$746K ﹤0.01% 1870
2022
Q4 		$10.2M Sell
67,729
-6,102
-8% -$939K ﹤0.01% 1834
2022
Q3 		$9.96M Buy
73,831
+4,018
+6% +$614K ﹤0.01% 1793
2022
Q2 		$10.4M Sell
69,813
-1,299
-2% -$198K ﹤0.01% 1825
2022
Q1 		$12.1M Buy
71,112
+1,900
+3% +$319K ﹤0.01% 1848
2021
Q4 		$17.8M Buy
69,212
+61,694
+821% +$16.9M ﹤0.01% 1643
2021
Q3 		$2.05M Buy
7,518
+1,323
+21% +$420K ﹤0.01% 2793
2021
Q2 		$1.39M Buy
+6,195
New +$1.17M ﹤0.01% 2997
2021
Q1 		– Sell
-20,468
Closed -$1.67M – 3864
2020
Q4 		$1.67M Sell
20,468
-574,404
-97% -$56.4M ﹤0.01% 2706
2020
Q3 		$41.2M Buy
594,872
+496,759
+506% +$35.6M 0.01% 1004
2020
Q2 		$6.55M Buy
+98,113
New +$4.9M ﹤0.01% 1850

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Invesco's BNTX Position: Q2 2026 in Review

Invesco increased its BioNTech (BNTX) stake by 9.4% in Q2 2026, buying an estimated $815K and bringing the position to 100,462 shares worth $9.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1936.

Invesco first reported a position in BNTX in Q2 2020 and has held it in 24 quarters since. The position peaked at $72.5M in Q2 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Invesco held 100,462 shares of BioNTech worth $9.35M as of Q2 2026.
  • Invesco bought 8,662 BioNTech shares in Q2 2026, an estimated $815K.
  • BioNTech made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #1936 holding.
  • Invesco first reported a position in BioNTech in Q2 2020 and has held it in 24 quarters since.
  • Invesco's BioNTech position peaked at $72.5M in Q2 2025.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.